Name | 6-chloro-5-methyl-N-quinolin-4-yl-2,3-dihydroindole-1-carboxamide |
---|---|
Synonyms |
HMS3262F03
Lopac-S-1068 6-Chloro-5-methyl-1-5-quinolycarbamoyl-indoline |
Description | SB-215505 is a potent and subtype-selective 5-HT2B receptor antagonist with pKi values of 8.3, 6.77, 7.66 for 5-HT2B, 5-HT2A, 5-HT2C, respectively[1]. SB-215505 increases wakefulness and motor activity in rats[2]. |
---|---|
Related Catalog | |
Target |
5-HT2B Receptor:8.3 (pKi) 5-HT2A Receptor:6.77 (pKi) 5-HT2C Receptor:7.66 (pKi) |
In Vitro | SB-215505 is 30 fold selective for the 5-HT2B over the 5-HT2A receptor, and only marginally selective over the 5-HT2C receptor[1]. |
In Vivo | SB-215505 (0.1-1.0 mg/kg; i.p.; two doses) dose-dependently increases wakefulness (W) and decreases IS, PS, SWS-2[2]. Animal Model: Male Sprague-Dawley rats weighing 230-260 g[2] Dosage: 0.1, 0.3 and 1.0 mg/kg Administration: IP; two doses (4 days between two doses) Result: Dose-dependently increased wakefulness (W) and decreased intermediate stage of sleep (IS), paradoxical sleep (PS), SWS-2. |
References |
Density | 1.385g/cm3 |
---|---|
Boiling Point | 600.9ºC at 760 mmHg |
Molecular Formula | C19H16ClN3O |
Molecular Weight | 337.80300 |
Flash Point | 317.2ºC |
Exact Mass | 337.09800 |
PSA | 48.46000 |
LogP | 4.27810 |
Vapour Pressure | 2.13E-14mmHg at 25°C |
Index of Refraction | 1.725 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |